Advanced Search
  • Users Online: 111
  • Print this page
  • Email this page

Current Issue

January-March 2019| Vol 2| Issue 1

Editorial

Optimizing Precision Oncology and Immunotherapy Strategies: Moving into the Next Stage of Cancer Medicine

Approved therapeutic options in cancer medicine have moved from traditional one-size-fits-all approaches with chemotherapy and radiation to now include precision medicine strategies utilizing molecu...

[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Original Article

The Study of Druggable Targets in Nonsquamous Non-Small-Cell Lung Cancer in the Middle East and North Africa

Background: Druggable molecular targets are very important in the management of non-small-cell lung cancer (NSCLC). The purpose of our study is to determine the pattern of testing and mutatio...

[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Commentary

Opening new boundaries in biomarker detection: Awakening of middle east and North Africa Region

Biomarker detection represents a new approach to better define the clinical management in lung cancer patients.[1],[2] In recent years, several new biomarkers were introduced in clinical practice. I...

[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Review Article

Extracellular signal-regulated kinase (ERK) inhibitors in oncology clinical trials

The mitogen-activated protein kinase (MAPK) pathway consists of the series of protein kinases RAS-RAF-MEK- Extracellular signal-regulated kinase (ERK), and its function is important to cell prolifer...

[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Special Article

5th Annual immuno-oncology 360° conference: What to expect

Drs. Axel Hoos (GSK), James Gulley (National Cancer Institute), and Andrew Baum (Citi) are co-chairing the fifth annual Immuno-Oncology 360° (IO360), a multidisciplinary conference addressing t...

[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
View All Articles in the Current Issue

Journal of Immunotherapy and Precision Oncology, a publication of Global Academy for Health Sciences, is a peer-reviewed print + online Quarterly journal.

Features of Manuscript Management System

  • Online submission
  • Wider visibility through open access
  • Higher impact
  • Prompt review
CALL FOR PAPERS
Special issue 2019

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, Netherlands ISSN center , ProQuest, TdNet, Wanfang Data

Online since 13th November 2017